| abstract |
The invention relates to a process for the preparation of compounds of formula (I) wherein Q 1 is a group selected from formulae (II) & (III) and a group *-NR 6 -Q 2 -A or, if appropriate, their pharmaceutically acceptable salts and/or isomers, tautomers, solvates or isotopic variations thereof, as well as intermediates used in said process. |